Horwitz L D, Rosenthal E A
Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262, USA.
Vasc Med. 1999;4(2):93-9. doi: 10.1177/1358836X9900400207.
Iron is an essential element for normal cellular function and general health. However, iron may play a pathologic role in certain cardiac conditions including reperfusion injury, hemochromatosis, beta-thalassemia and coronary atherosclerosis. It also may play a role in injury due to anthracycline cardiotoxicity. Removal of iron via phlebotomy for hemochromatosis and chelation therapy for beta-thalassemia are proven treatments. Cell culture, and isolated organ and animal studies suggest that depleting iron stores may prevent reperfusion injury, restenosis and even atherogenesis. This article will review mechanisms by which iron overload states and normal iron stores contribute to cardiovascular pathophysiology and the accumulating evidence that iron chelation may prevent restenosis and atherogenesis.
铁是正常细胞功能和整体健康所必需的元素。然而,铁在某些心脏疾病中可能发挥病理作用,包括再灌注损伤、血色素沉着症、β地中海贫血和冠状动脉粥样硬化。它在蒽环类药物心脏毒性导致的损伤中也可能起作用。通过放血治疗血色素沉着症来去除铁以及对β地中海贫血进行螯合治疗是已证实的治疗方法。细胞培养、离体器官和动物研究表明,减少铁储备可能预防再灌注损伤、再狭窄甚至动脉粥样硬化的发生。本文将综述铁过载状态和正常铁储备导致心血管病理生理的机制,以及铁螯合可能预防再狭窄和动脉粥样硬化的越来越多的证据。